13 results for "KENNETH ANDERSON"
Showing 1–13 · 1.80 seconds · RSS
-
Journal Article
Reseña de: Kitchen, Kenneth Anderson: Ramsés II, rey de Egipto. Su vida y su época
Reseña de: Kitchen, Kenneth Anderson: Ramsés II, rey de Egipto. Su vida y su época, Madrid, Editorial Dilema, 2022, 490 pp. + 20 láminas a color, ISBN: 978-84-9827-551-3.
-
Journal Article
Role of minimal residual disease assessment in multiple myeloma
Multiple myeloma (MM) is a hematologic malignancy characterized by clonal proliferation of plasma cells. MM is a heterogeneous disease, featured by various molecular subtypes with different outcomes. With the advent of very efficient therapies including monoclonal antibodies, bispecific T cell…
-
Journal Article Full text
Formation of Secondary Inorganic PM2.5 as Impacted by Ammonia Concentrations near an Animal Feeding Operation
The impact of ammonia (NH3) emissions from animal agriculture on the secondary formation of inorganic fine particulate matter (i.e., iPM2.5) has become of great public concern. The formation of iPM2.5 from NH3 is known as the gas–particle partitioning of gaseous NH3 and aerosol ammonium (NH4+)…
-
Journal Article
Wild Andean camelids promote rapid ecosystem development after glacier retreat
Abstract Knowing mechanisms that facilitate the emergence of post-glacial ecosystems is urgently required given rapid recent glacial retreat in high latitude and high elevation regions. We examined the effect of nutrient hotspots created via communal dung deposition by wild, native Andean camelids…
-
Journal Article
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel
Abstract Bispecific antibodies (BsAbs) are emerging as an important novel class of immunotherapeutic agents for the treatment of multiple myeloma (MM), and are set to be more widely used in clinical practice. However, this new class of therapies is associated with a distinct adverse event (AE)…
-
Journal Article
Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival
BackgroundMultiple Myeloma (MM) patients exhibit dysregulated immune system, which is further weakened by chemotherapeutic agents. While cereblon-modulating agents, such as pomalidomide and lenalidomide, have been found to improve the immune profile, the efficacy of their impact in combination with…
-
Journal Article
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
The causality and functional roles of disease-associated variants revealed by genome-wide association studies (GWAS) are mostly unexplored. Here the authors identify putative causal variants in multiple myeloma and find their association with gene expression and chromatin accessibility.